Related Articles
The efficacy and safety of first‑line anti‑PD‑1/PD‑L1 immunotherapy for gastric esophageal cancer: A systematic review and meta‑analysis of phase III randomized controlled trials
Survival analysis with regard to PD‑L1 and CD155 expression in human small cell lung cancer and a comparison with associated receptors
Exosomal PD‑L1 promotes the formation of an immunosuppressive microenvironment in gastric diffuse large B‑cell lymphoma
Expression of programmed cell death ligand‑1 protein in germinal center B‑cell‑like and non‑germinal center B‑cell‑like subtypes of diffuse large B‑cell lymphoma
Dynamic contrast‑enhanced MRI as a predictor of programmed death ligand‑1 expression in patients with oral squamous cell carcinoma